Drug intelligence / Profile preview

Shengyang Yiwei Tang

Development stage
Preclinical
Administration
Oral
01

Overview

Shengyang Yiwei Tang (升阳益胃汤) is a traditional Chinese herbal formula developed by Li Dongyuan, a prominent physician from the Jin-Yuan Dynasty. Traditionally, it is used to address conditions stemming from spleen and stomach deficiency, damp-heat stagnation in the middle jiao, and the inability of clear Yang to ascend. Symptoms treated include lethargy, weakness of limbs, body heaviness and joint pain, bitter taste in the mouth, dry tongue, tasteless food, indigestion, irregular bowel movements, frequent urination, and certain lung-related symptoms like aversion to cold and general malaise. Modern research, particularly through network pharmacology, has explored its potential in treating chronic kidney disease (CKD), including chronic glomerulonephritis, latent glomerulonephritis, urinary tract infection, and chronic renal insufficiency. This research suggests that the formula's active components, such as astragalus, ginseng, pinellia ternata, and coptis chinensis, exert therapeutic effects through multi-component, multi-target, and multi-pathway mechanisms, influencing various signaling pathways relevant to kidney health.

Other names
升阳益胃汤益胃汤Shengyang Yishen Tang升阳益肾汤

Beyond the preview

Go deeper on Shengyang Yiwei Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shengyang Yiwei Tang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call